Keloids are abnormal overgrowths of dermal fibrous tissue due to an exaggerated wound healing response after cutaneous insults. Although surgical excision is a common treatment option, recurrence rates after surgery can be high, especially without postoperative treatment modalities. 1 The current postoperative standard of care is to administer monthly intralesional triamcinolone injections. However, even for patients with a high disease burden (e.g., with multiple symptomatic keloids), there are no systemic treatments typically employed. 2 Pentoxifylline is a methylated xanthine derivative and a nonspecific phosphodiesterase inhibitor used to treat claudication from peripheral artery disease by reducing inflammation and increasing blood flow. Pentoxifylline has also been shown to inhibit the proliferation and rate of collagen synthesis of fibroblasts from keloids, scleroderma, and morpheain vitro. 3,4 Although not labeled for use in the treatment of keloids, pentoxifylline has been noted to decrease pain and itch and halt growth in severely symptomatic keloids. 5 To assess the clinical efficacy and side effect profile of oral pentoxifylline in keloid treatment, a retrospective, open-label pilot study analyzing postsurgical keloid recurrence rates was conducted. The primary goal of the present study was to determine whether the administration of postoperative oral pentoxifylline in patients who underwent keloid excision is associated with a decrease in keloid recurrence. MethodsThe Genetic Causes of Keloid Formation Study (GCKFS) is a University of Texas Southwestern Medical Center Institutional Review Board-approved research study. A retrospective study was performed on participants enrolled in the GCKFS; inclusion criteria included a diagnosis of keloids and at least one keloid surgically removed in 1 of 2 dermatologic clinics from October 2012 to December 2016. Exclusion criteria included A. Tan, O. Martinez Luna, and D.A. Glass II had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
United StatesMelanoDermÔ, supplied by MatTek Corporation, Ashland, MA is a commonly used in vitro model to test a formula or ingredient's impact on melanin and therefore their ability to even or lighten skin tone. MelanoDermÔ is a 3D constructed, live, manufactured skin culture that is widely used as a screening tool in the cosmetic industry to study melanogenesis and pigmentation. In this study, we evaluated well-known cosmetic compounds i.e. hydroquinone and kojic acid causing effects on melanin and melanogenesis in vivo, as relevant benchmark positive controls for in vitro screening architecture of other actives alone or in combination. Hydroquinone was tested in water solution as a single ingredient or as finished goods formulation at the concentration of 2% and Kojic Acid was investigated in water solutions at two different concentrations (1% and 2%) for their ability to reduce existing and new pigment formation on MelanoDermÔ (MEB-300B) tissues after 14 days of topical application. Cell viability was assessed with MTT assay, color measurements (L*, a*, b* values) with chromameter, and in situ histology of the selected tissues was performed with Hematoxylin and Eosin staining. Hydroquinone evaluation in this model was somewhat challenging due to its known cytotoxicity geared specifically towards melanocytes, while kojic acid was safe at the concentration of 1%. Generated data indicate that both actives may be used as positive controls and thus serve as a validated model in screening architecture of the new perspective skin lightening/brightening actives and represent a translation platform between vitro-to-vivo studies. It is well known that the cosmetic property of evening skin tone can help reduce the visible signs of aging on photodamaged skin. Photodamage originates from a variety of environmental aggressors including UV exposure, high energy visible light, and pollutants. Mel-anoDermÔ is a commonly used in vitro method to test a formula or ingredient's impact on melanin and therefore ability to even skin tone. MelanoDermÔ, supplied by MatTek Corporation, Ashland, MA, is a 3D constructed, live, synthetic skin culture that is widely used in the cosmetic industry. L-ascorbic acid is a known reactive oxygen species (ROS) scavenger and is often claimed to even skin tone through several biological pathways, including its ability to interrupt melanin synthesis by interacting with the copper ions at the active site of the enzyme Tyrosinase, a key enzyme in melanogenesis (pheomelanin and eumelanin); an increase in the amount and location of melanin in the skin is responsible for areas of uneven skin tone, and thus the appearance of aged skin upon exposure to environmental aggressors. This study was designed to test several topical dermatologics containing different levels of Lascorbic acid, and its esters, along with other ingredients in their ability reduce melanin pigment and its further formation on MelanoDermÔ (MEL-300B) tissues after 14 days of topical application. The CIE L*a*b* values were recorded with S...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.